$B:G=*99?7F|;~!'(B2022-01-31 16:50:01
vaccine (4$B7o(B) | ||||
---|---|---|---|---|
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-67 (2$B7o(B), ST-27 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
273 | $BHs?/=1@-%o%/%A%s%7!<%k$NAO@8$H$=$N5!G=@-I>2A(B | SY-67 | transdermal vaccine patch | 6/12 14:50:56 |
344 | $B%?%s%Q%/~$,2DG=$J<+8JAH?%2=%Z%W%A%I%U%!%$%P!<$NAO@=$H%o%/%A%s$X$NE83+(B | SY-68 | Self-assembled peptide enzymatic post-modification vaccine | 6/14 13:04:36 |
546 | [$B>7BT9V1i(B] $B%?%s%Q%/ | ST-27 | Protein polymerization Vaccine immunogenicity | 6/15 03:22:01 |
871 | $BBgD26]$K$*$1$k93BN@8;:NL$r8~>e$9$k(BcombiOGAB$B%F%/%N%m%8!<(B | SY-67 | combi OGAB antibody vaccine | 6/15 23:13:04 |
vacuum drying (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-71 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
810 | $B4%AgJ}K!$*$h$S>r7o$,9a5$@.J,$N4%Ag!&J4Kv2=$K5Z$\$91F6A(B | SY-71 | flavor retention vacuum drying spray drying | 6/15 18:54:37 |
Vacuum ultraviolet (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-61 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
247 | 146 nm$B$*$h$S(B172 nm$B??6u;g308w$rMxMQ$7$??75,(BCO2$B4T85K!$N3+H/(B | SY-61 | CO2 Vacuum ultraviolet | 6/11 17:45:22 |
vanadium (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-61 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
661 | $B%a%A%k%7%/%m%X%-%5%s$NC&?eAGH?1~$H$=$NJ,N%(B | SY-61 | dehydrogenation vanadium hydrogen separation | 6/15 13:57:53 |
vanadium redox flow battery (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B ST-24 (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
319 | $B%P%J%8%&%`%l%I%C%/%9%U%m! | ST-24 | vanadium redox flow battery membrane proton conductivity | 6/14 11:22:31 |
334 | $B%P%J%8%&%`%l%I%C%/%9%U%m! | ST-24 | CO2 activation treatment seamless porous carbon vanadium redox flow battery | 6/14 12:39:59 |
Vapor chamber (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-52 (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
575 | $B@QAX7?%Y!<%Q!<%A%c%s%P!<$K$h$k(BLED$B8w8;$K$*$1$k%8%c%s%/%7%g%s29EYDc8:$K4X$9$k8&5f(B | SY-52 | Vapor chamber LED substrate Thermal solution | 6/15 10:45:29 |
585 | $B@QAX7?%Y!<%Q!<%A%c%s%P!<$NG.E*FC@-$KBP$9$k@_CV;Q@*$N1F6A$NG.8;%5%$%:$K$h$kJQ2=(B | SY-52 | Vapor chamber Postural influence Heat source size | 6/15 10:58:38 |
Vapor phase synthesis (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-77 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
766 | $B%3%s%]%8%C%H6bB0%J%NN3;R$N5$Aj9g@.$*$h$S%b%kJ,N($N@)8f(B | SY-77 | Composite nanoparticles Vapor phase synthesis Mole fraction | 6/15 17:22:55 |
vapor pressure (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-51 (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
291 | $B0lHL2=>x5$05Aj4X<0$K$h$kNW3&Dj?t$*$h$SJP?40x;R$NM=B,(B | SY-51 | vapor pressure critical point acentric factor | 6/14 09:35:37 |
849 | $B>x5$05$N?d;;K!(B | SY-51 | vapor pressure vapor-liquid equilibrium prediction | 6/15 20:54:26 |
vapor-liquid equilibrium (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-51 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
849 | $B>x5$05$N?d;;K!(B | SY-51 | vapor pressure vapor-liquid equilibrium prediction | 6/15 20:54:26 |
vaporization (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B ST-22 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
594 | $B%Q%k%96!5k(BALD$B$K$*$1$k86NA5$2=FC@-$N8!F$(B | ST-22 | ALD precursor vaporization | 6/15 11:21:07 |
Variants of concern (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-70 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
733 | Quenchbody$B$rMQ$$$?(B1$BJ,4V(BSARS-CoV-2$B5Z$SJQ0[3t$N8!=PK!(B | SY-70 | SARS-CoV-2 Quenchbody Variants of concern | 6/15 16:16:43 |
Velocity field (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-52 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
386 | Flow Focusing$B$K$h$k%@%V%k%(%^%k%7%g%s$N@8@.$H1UE)<~0O$NB.EY>l7WB,(B | SY-52 | Flow Focusing Double emulsion Velocity field | 6/14 14:58:12 |
VHH (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-67 (2$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
378 | DO-stat$BN.2CG]M\$K$h$kAH49$(BgD26]$rMQ$$$?93BN%U%i%0%a%s%H(BVHH$B$N6]BN30@8;:(B | SY-67 | Extracelluar production VHH E.coli | 6/14 14:43:23 |
686 | $B%$%s%U%k%(%s%68!::$N9b46EY2=$rL\;X$7$?(B VHH $B93BN$NC1N%$H9b5!G=2=(B | SY-67 | Immunochromatography Screening VHH | 6/15 14:42:20 |
Virus filter (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-72 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
529 | $B%+%i%`%W%m%;%9$H%&%#%k%9%U%#%k%?!<$rD>7k$7$?(BIntegrated process$B$N8!F$(B | SY-72 | Virus filter Chromatography Integrated process | 6/14 21:48:45 |
Visco-elastic fluid (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-55 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
884 | [$BE8K>9V1i(B] $B%F%$%i!<12$N0BDj@-$K4X$9$k8&5f(B | SY-55 | Stability of Taylor vortex Coating Visco-elastic fluid | 6/28 12:30:58 |
Viscoelasticity (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-52 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
819 | $B<42AJ}K!$N8!F$(B | SY-52 | Viscoelasticity Frictional resistance reduction Channeling | 6/15 19:24:47 |
Viscoelasticity fluid (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-53 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
274 | $B05NO?6F0>l$K$*$1$kFC0[5$K"7A>u$N7A@.$K4X$9$kG4CF@-$N1F6A$N8!F$(B | SY-53 | pressure oscillation Viscoelasticity fluid 2D high-speed polarization imaging | 6/12 15:29:35 |
viscosity (3$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-51 (2$B7o(B), SY-53 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
203 | $B%k!<%W4I7?N.DLAuCVCf$K$*$1$k(BHFC134a$B%O%$%I%l!<%H%9%i%j!<$NN.F05sF0(B | SY-53 | hydrate slurry flow characteristic viscosity | 6/11 11:02:32 |
299 | [$B>7BT9V1i(B] $B%0%j!<%s%W%m%;%9!&%^%F%j%"%k$N$?$a$N4pACJ*@-$N?75,I>2AK!$HB,Dj@:EY8~>e$N | SY-51 | Ionic liquid phase equilibria viscosity | 6/14 10:20:33 |
602 | $BD69bG;EYNN0h$K$*$1$kM-5!=$>~6bB0;@2=J*%J%NN3;RJ,;61U$NG4@-5sF0(B | SY-51 | nanoparticle viscosity | 6/15 11:41:41 |
VOF (2$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-81 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
329 | $B%+!<%F%s%3!<%F%#%s%0$K$*$1$kN.2<1UKl$N0BDj2=$K4X$9$k?tCME*8&5f(B | SY-81 | Curtain Coating VOF Air Shield | 6/14 12:10:48 |
531 | $B%$%s%/%8%'%C%H0u:~$K$*$1$k1UE)EG=P$*$h$SCeCF%7%_%e%l!<%7%g%s(B | SY-53 | inkjet VOF droplets | 6/14 22:07:00 |
void fraction (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-56 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
382 | $B%7%j%+9E3L%^%$%/%m%+%W%;%k$N3L8|!&Cf6uN($K4X$9$k8&5f(B | SY-56 | silica microcapsule shell thickness void fraction | 6/14 14:51:34 |
Volume of fluid (1$B7o(B) | ||||
$B$3$N%-!<%o!<%I$,$h$/;H$o$l$F$$$k%7%s%]%8%&%`!&9V1iJ,N`!'(B SY-53 (1$B7o(B) | ||||
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $B | | |
173 | $BEE>l2<$K$*$1$k | SY-53 | Volume of fluid breakup electric field | 6/10 16:17:17 |